Fig. 3.
Comparison of gastric motility between EPS patients with pancreatic enzyme abnormalities and EPS patients without it. (A) There are no significant differences in Tmax and T1/2 values among EPS patients with pancreatic enzyme abnormalities, EPS patients without it and PDS patients. (B) AUC5 and AUC15 values in EPS patients with pancreatic enzyme abnormalities were significantly disturbed compared to those in EPS patients without pancreatic enzyme abnormalities. *p = 0.002, vs EPS patients without pancreatic enzyme abnormalities. **p = 0.001, vs EPS patients without pancreatic enzyme abnormalities.